We are live on ! Find out more
APTX

Aptinyx Inc. Common Stock

Delisted

APTX was delisted on the 18th of May, 2023.

3 hedge funds and large institutions have $24K invested in Aptinyx Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

91% less funds holding

Funds holding: 323 (-29)

99% less capital invested

Capital invested by funds: $2.44M → $24K (-$2.42M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 29

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
3
Holders Change
-29
Holders Change %
-90.63%
% of All Funds
0.05%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
Increased
Reduced
1
Closed
29
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
CWP
26
Concord Wealth Partners
Virginia
-$1.2K -10,000 Closed
FDCDDQ
27
Federation des caisses Desjardins du Quebec
Quebec, Canada
-$375 -3,000 Closed
AF
28
Allworth Financial
California
-$125 -1,000 Closed
Bank of America
29
Bank of America
North Carolina
-$99 -800 Closed
Wells Fargo
30
Wells Fargo
California
-$96 -772 Closed
Osaic Holdings
31
Osaic Holdings
Arizona
-$13 -110 Closed

APTX Hedge Fund Activity: Q2 2023 in Review

3 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Aptinyx Inc. Common Stock (APTX) for Q2 2023, worth a combined $24K — down 99% from $2.44M a quarter earlier.

Sellers outnumbered buyers: 29 funds closed out of APTX and 0 opened new positions — a net loss of 29 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Bain Capital Life Sciences Investors, exiting entirely with an estimated $1.11M sold.

  • 3 institutional investors held Aptinyx Inc. Common Stock (APTX) as of Q2 2023, down from 32 in Q1 2023.
  • Funds reported $24K of Aptinyx Inc. Common Stock stock for Q2 2023, down 99% quarter-over-quarter.
  • 0 funds opened new Aptinyx Inc. Common Stock positions in Q2 2023 and 29 closed out, a net change of -29 holders.
  • The largest Aptinyx Inc. Common Stock seller in Q2 2023 was Bain Capital Life Sciences Investors, an estimated $1.11M sold.

Based on aggregated 13F filings for Q2 2023.